Procalcitonin serum levels in patients with stage IV non-small cell lung cancer in first line of chemotherapy

被引：1
|
作者：
Garoutte, Camille
Poulet, Claire
Obstler, Jean Baptiste
Bourgeois, Anne-Marie
Khamis, Warda
Dewolf, Maxime
Faouzi, Sara
Galmiche, Antoine
Jounieaux, Vincent
Andrejak, Claire
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2016年 / 48卷
关键词：
Biomarkers; Lung cancer / Oncology; Infections;
D O I：
10.1183/13993003.congress-2016.PA2822
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA2822
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Chemotherapy beyond first-line in stage IV metastatic non-small cell lung cancer
    Younes, Riad Naim
    Pereira, Jost Rodrigues
    Fares, Abdo Latif
    Gross, Jefferson Luiz
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2011, 57 (06): : 686 - 691
  • [2] Irinotecan and docetaxel as first-line chemotherapy in patients with stage IIIB/IV non-small cell lung cancer.
    Raez, LE
    Rosado, M
    Santos, ES
    Hamilton, K
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 677S - 677S
  • [3] Extremely elevated serum procalcitonin concentration in a patient with stage IV non-small cell lung cancer
    Stando, Rafal
    Chmielewski, Grzegorz
    ARCHIVES OF MEDICAL SCIENCE, 2023, 19 (05) : 1581 - 1583
  • [4] Indications for chemotherapy in stage IV non-small cell lung cancer
    Gatzemeier, U
    LUNG CANCER, 2001, 33 : S109 - S113
  • [5] Use of chemotherapy for patients with stage IV non-small cell lung cancer.
    Waqar, Sadaf Huma
    Waqar, Saiama Naheed
    Devarakonda, Siddhartha
    Gao, Feng
    Robinson, Cliff Grant
    Puri, Varun
    Govindan, Ramaswamy
    Morgensztern, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] Treatment intensity and duration in patients receiving first-line taxane chemotherapy for stage IV non-small cell lung cancer.
    Weiss, Jared
    Force, Rex W.
    Pugmire, Brooke A.
    Peterson, Teri
    Faria, Claudio
    Margunato-Debay, Sandra
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [7] Serum C-reactive protein and procalcitonin levels in non-small cell lung cancer patients
    Tulek, Baykal
    Koylu, Habibe
    Kanat, Fikret
    Arslan, Ugur
    Ozer, Faruk
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2013, 17 (01): : 68 - 72
  • [8] Serum C-reactive protein and procalcitonin levels in non-small cell lung cancer patients
    Tulek, Baykal
    Koylu, Habibe
    Kanat, Fikret
    Arslan, Ugur
    Ozer, Faruk
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [9] Pemetrexed, oxaliplatin and bevacizumab as first-line treatment in patients with stage IV non-small cell lung cancer
    Mir, Olivier
    Boudou-Rouquette, Pascaline
    Giroux, Julie
    Chapron, Jeanne
    Alexandre, Jerome
    Gibault, Laure
    Ropert, Stanislas
    Coriat, Romain
    Durand, Jean-Philippe
    Burgel, Pierre-Regis
    Dusser, Daniel
    Goldwasser, Francois
    LUNG CANCER, 2012, 77 (01) : 104 - 109
  • [10] First-line systemic treatment with gefitinib in stage IV non-small cell lung cancer
    Lange, T
    Müller-Tidow, C
    Serve, H
    Hoffknecht, P
    Berdel, WE
    Thomas, M
    ONCOLOGY REPORTS, 2005, 14 (06) : 1539 - 1542
12345